SI1095040T1 - New benzoxazoles with pde-inhibiting activity - Google Patents

New benzoxazoles with pde-inhibiting activity

Info

Publication number
SI1095040T1
SI1095040T1 SI9930588T SI9930588T SI1095040T1 SI 1095040 T1 SI1095040 T1 SI 1095040T1 SI 9930588 T SI9930588 T SI 9930588T SI 9930588 T SI9930588 T SI 9930588T SI 1095040 T1 SI1095040 T1 SI 1095040T1
Authority
SI
Slovenia
Prior art keywords
pde
inhibiting activity
benzoxazoles
new
new benzoxazoles
Prior art date
Application number
SI9930588T
Other languages
English (en)
Slovenian (sl)
Inventor
Wolf-R�diger ULRICH
Hermann Amschler
Thomas Br
Dieter Flockerzi
Beate Schmidt
Ulrich Thibaut
Armin Hatzelmann
Hildegard Boss
Rolf Beume
Hans-Peter Kley
Dietrich H�FNER
Thomas Martin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1095040T1 publication Critical patent/SI1095040T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9930588T 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity SI1095040T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98112469 1998-07-06
PCT/EP1999/004451 WO2000001695A1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity
EP99931198A EP1095040B1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Publications (1)

Publication Number Publication Date
SI1095040T1 true SI1095040T1 (en) 2004-10-31

Family

ID=8232222

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930588T SI1095040T1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Country Status (14)

Country Link
US (1) US6376485B1 (da)
EP (1) EP1095040B1 (da)
JP (1) JP2002519423A (da)
AT (1) ATE263166T1 (da)
AU (1) AU761647B2 (da)
CA (1) CA2336894A1 (da)
DE (1) DE69916066T2 (da)
DK (1) DK1095040T3 (da)
ES (1) ES2219031T3 (da)
IL (1) IL140468A0 (da)
PT (1) PT1095040E (da)
SI (1) SI1095040T1 (da)
WO (1) WO2000001695A1 (da)
ZA (1) ZA200100088B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2225215A1 (en) 2007-11-21 2010-09-08 Decode Genetics EHF Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405633A (en) * 1982-03-01 1983-09-20 Usv Pharmaceutical Corporation Method of treatment of asthma
US4490373A (en) * 1983-05-20 1984-12-25 Usv Pharmaceutical Corporation Method of treating asthma
EP0785927B1 (en) * 1994-10-12 2003-08-27 Euroceltique S.A. Novel benzoxazoles
WO1996036626A1 (de) * 1995-05-18 1996-11-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Cyclohexyldihydrobenzofurane
PT771794E (pt) * 1995-05-19 2006-09-29 Kyowa Hakko Kogyo Kk Compostos heterociclicos contendo oxigenio

Also Published As

Publication number Publication date
ES2219031T3 (es) 2004-11-16
US6376485B1 (en) 2002-04-23
AU761647B2 (en) 2003-06-05
EP1095040B1 (en) 2004-03-31
DK1095040T3 (da) 2004-07-26
IL140468A0 (en) 2002-02-10
ZA200100088B (en) 2002-05-06
JP2002519423A (ja) 2002-07-02
CA2336894A1 (en) 2000-01-13
AU4778699A (en) 2000-01-24
DE69916066D1 (de) 2004-05-06
ATE263166T1 (de) 2004-04-15
PT1095040E (pt) 2004-08-31
WO2000001695A1 (en) 2000-01-13
EP1095040A1 (en) 2001-05-02
DE69916066T2 (de) 2005-02-24

Similar Documents

Publication Publication Date Title
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
YU37903A (sh) POSTUPCI LEČENJA STANJA POVEZANIH SA p38 KINAZOM I JEDINJENJA PIROLOTRIAZINA KOJA SE KORISTE KAO INHIBITORI KINAZE
AU2003215753A1 (en) Imidazopyridine derivatives as kinase inhibitors
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
SE0202463D0 (sv) Novel compounds
RS20050462A (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
SI1095040T1 (en) New benzoxazoles with pde-inhibiting activity
AP2000002016A0 (en) 2-(Purin-9-yl) Tetrahydrofuran-3,4-diol derivatives.
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
RS105204A (en) Substituted 3-amino-thieno/2,3-b/pyridine- 2-carboxylic acid amide compounds and processes for preparing and their uses
GEP20084357B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
NZ527249A (en) Purine derivatives as purinergic receptor antagonists
MY135920A (en) New phenalkyloxy-phenyl derivatives
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ES2189871T3 (es) Ciclohexil-dihidro-benzofuranos.
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
PL359409A1 (en) Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
MXPA03003798A (es) Derivados triciclicos de indol con actividad antiangiogenica.
MXPA05012772A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.
TW200504076A (en) 7-imino derivatives camptothecin having antitumor activity